Injectable beta-lactamase inhibitors combined with beta-lactam antibiotics for enhanced efficacy against resistant pathogens. Manufactured by pharmaceutical companies and supplied to hospitals, surgical centers, and procurement departments in healthcare facilities for intravenous administration in infection treatment protocols.